Literature DB >> 12621044

The crystal structure and stereospecificity of levodione reductase from Corynebacterium aquaticum M-13.

Satoshi Sogabe1, Ayumi Yoshizumi, Takaaki A Fukami, Yasuhiko Shiratori, Sakayu Shimizu, Hiroshi Takagi, Shigeru Nakamori, Masaru Wada.   

Abstract

The (6R)-2,2,6-trimethyl-1,4-cyclohexanedione (levodione) reductase (LVR) of the soil isolate bacterium Corynebacterium aquaticum M-13 is a NAD(H)-linked enzyme that catalyzes reversible oxidoreduction between (4R)-hydroxy-(6R)-2,2,6-trimethylcyclohexanone (actinol) and levodione. Here the crystal structure of a ternary complex of LVR with NADH and its inhibitor 2-methyl-2,4-pentanediol has been determined by molecular replacement and refined at 1.6-A resolution with a crystallographic R factor of 0.199. The overall structure is similar to those of other short-chain alcohol dehydrogenase/reductase enzymes. The positions of NADH and 2-methyl-2,4-pentanediol indicate the binding site of the substrate and identify residues that are likely to be important in the catalytic reaction. Modeling of the substrate binding in the active site suggests that the specificity of LVR is determined by electrostatic interactions between the negatively charged surface of Glu-103 of LVR and the positively charged surface on the re side of levodione. Mutant LVR enzymes in which Glu-103 is substituted with alanine (E103A), glutamine (E103Q), asparagines (E103N), or aspartic acid (E103D) show a 2-6-fold increase in Km values as compared with wild-type LVR and a much lower enantiomeric excess of the reaction products (60%) than the wild-type enzyme (95%). Together, these data indicate that Glu-103 has an important role in determining the stereospecificity of LVR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12621044     DOI: 10.1074/jbc.M208146200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Structural and functional characterization of BaiA, an enzyme involved in secondary bile acid synthesis in human gut microbe.

Authors:  Shiva Bhowmik; David H Jones; Hsien-Po Chiu; In-Hee Park; Hsiu-Ju Chiu; Herbert L Axelrod; Carol L Farr; Henry J Tien; Sanjay Agarwalla; Scott A Lesley
Journal:  Proteins       Date:  2013-10-17

2.  High-affinity inhibitors of human NAD-dependent 15-hydroxyprostaglandin dehydrogenase: mechanisms of inhibition and structure-activity relationships.

Authors:  Frank H Niesen; Lena Schultz; Ajit Jadhav; Chitra Bhatia; Kunde Guo; David J Maloney; Ewa S Pilka; Minghua Wang; Udo Oppermann; Tom D Heightman; Anton Simeonov
Journal:  PLoS One       Date:  2010-11-02       Impact factor: 3.240

3.  Structural basis of stereospecific reduction by quinuclidinone reductase.

Authors:  Daijiro Takeshita; Michihiko Kataoka; Takuya Miyakawa; Ken-Ichi Miyazono; Shoko Kumashiro; Takahiro Nagai; Nobuyuki Urano; Atsuko Uzura; Koji Nagata; Sakayu Shimizu; Masaru Tanokura
Journal:  AMB Express       Date:  2014-02-07       Impact factor: 3.298

4.  Catabolism of the Last Two Steroid Rings in Mycobacterium tuberculosis and Other Bacteria.

Authors:  Adam M Crowe; Israël Casabon; Kirstin L Brown; Jie Liu; Jennifer Lian; Jason C Rogalski; Timothy E Hurst; Victor Snieckus; Leonard J Foster; Lindsay D Eltis
Journal:  mBio       Date:  2017-04-04       Impact factor: 7.867

5.  Crystal structure of a putative short-chain dehydrogenase/reductase from Paraburkholderia xenovorans.

Authors:  Jaysón Davidson; Kyndall Nicholas; Jeremy Young; Deborah G Conrady; Stephen Mayclin; Sandhya Subramanian; Bart L Staker; Peter J Myler; Oluwatoyin A Asojo
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2022-01-01       Impact factor: 1.056

6.  3-oxoacyl-ACP reductase from Schistosoma japonicum: integrated in silico-in vitro strategy for discovering antischistosomal lead compounds.

Authors:  Jian Liu; Dave Dyer; Jipeng Wang; Shuqi Wang; Xiaofeng Du; Bin Xu; Haobing Zhang; Xiaoning Wang; Wei Hu
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.